Each year in late spring our Pilot & Feasibility Program issues a call for proposals. Following review by external experts, five outstanding projects were chosen for funding:
1. Boris Calderon, M.D.
“Tracing the ontogeny and turnover rate of islet resident macrophages”
2. Brian Finck, Ph.D.
“Mitochondrial pyruvate transport and beta cell function”
3. Simon Haroutounian, Ph.D.
“Predicting individual response to analgesic treatment in painful diabetic neuropathy and improving
nonverbal assessment of pain relief”
4. Colin Nichols, Ph.D.
“Zebrafish model of excitability-driven diabetes”
5. M. Yanina Pepino de Gruev, Ph.D.
“Metabolic effects of non-nutritive sweeteners”